Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The clinical course of calpainopathy (LGMD2A) and dysferlinopathy (LGMD2B).

Neurological research - 1 Feb 2010

Angelini C, Nardetto L, Borsato C, Padoan R, Fanin M, Nascimbeni A C, Tasca E

Abstract excerpt

OBJECTIVE: Autosomal recessive limb girdle muscular dystrophies (LGMD type 2) are a clinically and genetically heterogeneous group of disorders, characterized by progressive involvement and wasting of limb girdle muscles. In order to describe the peculiar clinical features of LGMD2A (calpainopathy) and LGMD2B (dysferlinopathy), the most frequent forms of LGMD in European countries, we analysed and compared the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age of Onset
Share to Child
Share to Child, Preschool

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Progression

Share to Muscular Dystrophies, Limb-Girdle

Share to Neurologic Examination

Share to Severity of Illness Index

Share to Young Adult

Source

Identifiers

PMID: 20092694
DOI: 10.1179/174313209X380847

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The clinical course of calpainopathy (LGMD2A) and dysferlinopathy (LGMD2B).PMID 20092694Read ↗

Limb–girdle muscular dystrophiesSemantic proximity Read ↗

Natural history of LGMD 2A for delineating outcome measures in clinical trialsSemantic proximity Read ↗

Clinical, molecular, and protein correlations in a large sample of genetically diagnosed Italian limb girdle muscular dystrophy patients.Semantic proximity Read ↗

The clinical spectrum and genetic variability of limb-girdle muscular dystrophy in a cohort of Chinese patients.Semantic proximity Read ↗

Seven autosomal recessive limb-girdle muscular dystrophies in the Brazilian population: from LGMD2A to LGMD2G.Semantic proximity Read ↗

Dysferlinopathy in Tunisia: clinical spectrum, genetic background and prognostic profile.Semantic proximity Read ↗

Phenotypic and genotypic analysis of limb-Girdle muscular dystrophy type 2B.Semantic proximity Read ↗

Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2B.Semantic proximity Read ↗

Dysferlinopathy (LGMD2B): a 23-year follow-up study of 10 patients homozygous for the same frameshifting dysferlin mutations.Semantic proximity Read ↗

Genetic basis of limb-girdle muscular dystrophies: the 2014 update.Semantic proximity Read ↗

Limb girdle muscular dystrophies: classification, clinical spectrum and emerging therapies.Semantic proximity Read ↗

[Limb girdle muscular dystrophies].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.